Patient‐reported outcome and experience measures in prostate surgery (holmium laser enucleation and robot radical prostatectomy) von Van Vaerenbergh, Brecht, De Pauw, Marleen

Volltext

The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects von Van den Bogaert, Walter, van der Schueren, Emmanuel, Horiot, Jean-Claude, De Vilhena, Mario, Schraub, Simon, Svoboda, Vladimir, Arcangeli, Giorgio, de Pauw, Marleen, Van Glabbeke, Martine

Volltext

The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: prognostic factors von Van den Bogaert, Walter, van der Schueren, Emmanuel, Horiot, Jean Claude, De Vilhena, Mario, Schraub, Simon, Svoboda, Vladimir, Arcangeli, Giorgio, de Pauw, Marleen, van Glabbeke, Martine

Volltext

Maximum Androgen Blockade Using LHRH Agonist Buserelin in Combination with Short-Term (Two Weeks) or Long-Term (Continuous) Cyproterone Acetate Is Not Superior to Standard Androgen... von de Voogt, Herman J., Studer, Urs, Schröder, Fritz H., Klijn, Jan G., de Pauw, Marleen, Sylvester, Richard

Volltext

The eortc randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: Long-term results and side effects von Van den Bogaert, Walter, van der Schueren, Emmanuel, Horiot, Jean-Claude, De Vilhena, Mario, Schraub, Simon, Svoboda, Vladimir, Arcangeli, Giorgio, de Pauw, Marleen, Van Glabbeke, Martine

Volltext

Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer von van den Bogaert, Walter, van der Schueren, Emmanuel, Horiot, Jean-Claude, Chaplain, Gilles, Devilhena, Mario, Raposo, Silva, Leonor, Jorge, Schraub, Simon, Chenal, Christian, Barthelme, Eric, Daban, Alain, Eschwege, Francois, Gonzalez, Dionisio, Leer, Jan-Willem, Hamers, Han, Svoboda, Vladimir, Rigon, Alberto, Arcangeli, Giorgio, Sack, Horst, de Pauw, Marleen, van Glabbeke, Martine

Volltext

Low-dose fortnightly methotrexate in advanced prostate cancer von Jones, William G., Fosså, Sophie D., Verbaeys, Antony C., Droz, Jean-Pierre, Klijn, Jan G.M., Boven, Epie, de Pauw, Marleen, Sylvester, Richard

Volltext

The chemotherapy of advanced bladder cancer von Newling, D W, Stoter, G, Sylvester, R, de Pauw, M

Volltext

Quality of Institutional Participation in Multicenter Clinical Trials von Sylvester, Richard J, Pinedo, Herbert M, Pauw, Marleen De, Staquet, Maurice J, Buyse, Marc E, Renard, Josette, Bonadonna, Gianni

Volltext

Long-term follow-up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgery von Jansen, Rob L.H., Sylvester, Richard, Sleyfer, Dirk T., ten Bokkel Huinink, Wim W., Kaye, Stan B., Jones, William G., Keizer, Jan, van Oosterom, Allan T., Meyer, Sybren, P.J. Vendrik, Cornelis, de Pauw, Marleen, Stoter, Gerrit

Volltext

TCNU in advanced renal cancer von van Oosterom, Allan T., Pierre Droz, Jean, Fossa, Sophie T., Bono, Aldo V., Splinter, Ted A.W., Verbaeys, Antoni J., Keizer, Jan, de Pauw, Marleen, Sylvester, Richard

Volltext

Vindesine in advanced renal cancer. A study of the EORTC genito-urinary tract cancer cooperative group von Fosså, Sophie D., Denis, Louis, Van Oosterom, Allan T., De Pauw, Marleen, Stoter, Gerrit

Volltext

A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer von Fosså, Sophie D., Splinter, Ted, Roozendaal, Klaas J., Veenhof, Kees H.N., Pavone-Macaluso, Michele, Calciati, Alessandro, de Pauw, Marleen, Sylvester, Richard

Volltext

4′Deoxydoxorubicin in advanced renal cancer von van Oosterom, Allan T., Bono, Aldo V., Kaye, Stan B., Splinter, Ted A.W., Calciati, Alessandro, Fosså, Sophie D., Pauw, Marleen de, Sylvester, Richard

Volltext

4′Deoxydoxorubicin in advanced renal cancer: A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group von van Oosterom, Allan T., Bono, Aldo V., Kaye, Stan B., Splinter, Ted A.W., Calciati, Alessandro, Fosså, Sophie D., Pauw, Marleen de, Sylvester, Richard

Volltext

A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer: EORTC-GU Group Protocol 30867 von FOSSA, S. D, SPLINTER, T, ROOZENDAAL, K. J, VEENHOF, K. H. N, PAVONE-MACALUSO, M, CALCIATI, A, DE PAUW, M, SYLVESTER, R

Volltext

Mitozolomide in advanced renal cancer: A phase II study in previously untreated patients from the EORTC genito-urinary tract cancer cooperative group von Van Oosterom, Allan T., Stoter, Gerrit, Bono, Aldo V., Splinter, Ted A.W., Fossa, Sophie D., Verbaeys, Antoni J., De Mulder, Pieter H.M., De Pauw, Marleen, Sylvester, Richard

Volltext

Mitoxantrone in advanced bladder carcinoma. A phase II study of the EORTC genito-urinary tract cancer cooperative group von Van Oosterom, Allan T., Fosså, Sophie D., Mulder, Jannes H., Calciati, Alessandro, de Pauw, Marleen, Sylvester, Richard

Volltext

Mitozolomide in advanced renal cancer von Van Oosterom, Allan T., Stoter, Gerrit, Bono, Aldo V., Splinter, Ted A.W., Fossa, Sophie D., Verbaeys, Antoni J., De Mulder, Pieter H.M., De Pauw, Marleen, Sylvester, Richard

Volltext

Mitoxantrone in advanced renal cancer: A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group von van Oosterom, Allan T., Fosså, Sophie D., Pizzocaro, Giorgio, Bergerat, Jean Pierre, Bono, Aldo V., de Pauw, Marleen, Sylvester, Richard

Volltext